Address
Kreos Capital
25-28 Old Burlington Street
London
W1S 3AN
United Kingdom
Phone
Website
Recent investment activity
KANDO id: 3537
Corporate information
Registration country
Previously known as
Company type
Provider of flexible debt solutions to equity-backed, pan-European and Israeli high-growth companies in the technology and healthcare sectors.Funding rounds
Actual initial investment stage
Debt (2)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 71| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
|
Funnel Operations AB (Funnel) | Series B | ||||
|
Signal Media Ltd (Signal AI) | Series B | ||||
|
The Currency Cloud Ltd (Currencycloud) | Payments automation platform designed to remit cross boarder payments through API. | Debt Initial investment led the round | |||
|
|
Signal Media Ltd (Signal AI) | Debt led the round | ||||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Abiquo Group Inc | Debt USD 1,360,000 (USD 1,360,000) | ||||
|
|
Advasense Technologies Ltd | N/A | ||||
|
|
INSIDE Secure SA | N/A | ||||
|
|
Norstel AB | N/A | ||||
|
|
Iamba Networks Inc | Gigabit passive optical networks solutions company for telecommunications equipment manufacturers and original device manufacturers. | N/A | |||
|
|
Crocus Technology | N/A | ||||
|
|
Valens Semiconductor Ltd | N/A | ||||
|
|
Upfront Chromatography AS | N/A | ||||
|
|
Tribold Ltd | N/A | ||||
|
|
SpineVision SA | N/A | ||||
|
|
Silex Microsystems AB | N/A | ||||
|
Silecs Oy | Advanced semiconductor materials. | N/A | |||
|
|
Siano Mobile Silicon Inc | N/A | ||||
|
|
PrimeSense Ltd | N/A | ||||
|
|
Polatis Inc | N/A | ||||
|
|
PacketFront Sweden AB | N/A | ||||
|
Openet Telecom Ltd | N/A | ||||
|
|
Openbravo SL | N/A | ||||
|
|
Odersun AG | N/A | ||||
|
|
NTRglobal | A Spanish-based developer of software as a service solutions, offers remote support, remote access and remote systems management solutions. | N/A |
| Company | Profile | Country | Funding | ||
|---|---|---|---|---|---|
|
Calliditas Therapeutics AB | Biopharma company focused on identifying, developing, and commercialising novel treatments in orphan indications with significant unmet medical needs. | Debt Initial investment led the round EUR 68,000,000 Exited Repayment of preference shares/ loans or mezzanine |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Ross Ahlgren (founder) | [email protected] | |||
| Maurizio Petit Bon (founder) | [email protected] | |||
| Raoul Stein | [email protected] | |||
| Mårten Vading | [email protected] |